The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

Medical professionals at Thomas Hospital successfully performed a new procedure to treat early-stage, low-risk breast tumors ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

Cancer treatment can take a profound financial toll, and new research shows the damage does not stop at the bank account.

Slated for March 12, The Dana-Farber Cancer Institute's Breakfast with the Doctors will feature a discussion between five ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.